BTAIVSGTBP• 12 Months (Normalized)
BTAI vs GTBP (BioXcel Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-98.75%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-98.75 pts
GTBP outperforming by 98.75 percentage points
BTAIGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BTAI Price | BTAI Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $0.04 | -98.75% | $- | - | |
| Sep 23, 2026 | $0.05 | -98.40% | $7.10 | +832.98% | -931.38% |
| Sep 22, 2026 | $0.04 | -98.42% | $- | - | |
| Sep 21, 2026 | $0.06 | -97.82% | $7.18 | +843.50% | -941.32% |
| Sep 18, 2026 | $0.06 | -97.94% | $7.16 | +840.87% | -938.81% |
| Sep 17, 2026 | $0.08 | -97.34% | $7.49 | +884.23% | -981.57% |
| Sep 16, 2026 | $0.07 | -97.63% | $7.81 | +926.28% | -1023.91% |
| Sep 15, 2026 | $0.04 | -98.41% | $9.00 | +1082.65% | -1181.06% |
| Sep 14, 2026 | $0.05 | -98.40% | $11.63 | +1428.25% | -1526.65% |
| Sep 11, 2026 | $0.05 | -98.19% | $8.61 | +1031.41% | -1129.60% |
| Sep 10, 2026 | $0.05 | -98.23% | $6.18 | +712.09% | -810.32% |
| Sep 09, 2026 | $0.05 | -98.33% | $5.98 | +685.81% | -784.14% |
| Sep 08, 2026 | $0.04 | -98.48% | $- | - | |
| Sep 04, 2026 | $0.07 | -97.38% | $0.24 | -68.33% | -29.05% |
| Sep 03, 2026 | $0.12 | -95.82% | $0.25 | -66.89% | -28.93% |
Page 1 of 17